Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Athira Pharma Inc (ATHA)

Athira Pharma Inc (ATHA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 22,505
  • Shares Outstanding, K 38,669
  • Annual Sales, $ 0 K
  • Annual Income, $ -117,670 K
  • EBIT $ -116 M
  • EBITDA $ -116 M
  • 60-Month Beta 2.99
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 0.40
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -2.85
  • Most Recent Earnings $-0.75 on 11/07/24
  • Next Earnings Date 11/14/24
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Options Overview Details

View History
  • Implied Volatility 1,003.46% ( +358.77%)
  • Historical Volatility 142.17%
  • IV Percentile 100%
  • IV Rank 100.00%
  • IV High 1,003.46% on 12/13/24
  • IV Low 15.10% on 03/15/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 14
  • Volume Avg (30-Day) 33
  • Put/Call OI Ratio 0.07
  • Today's Open Interest 2,268
  • Open Int (30-Day) 2,231

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -0.23
  • Number of Estimates 1
  • High Estimate -0.23
  • Low Estimate -0.23
  • Prior Year -0.71
  • Growth Rate Est. (year over year) +67.61%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.5639 +3.72%
on 12/12/24
0.7472 -21.72%
on 11/14/24
-0.1451 (-19.88%)
since 11/13/24
3-Month
0.4115 +42.14%
on 09/26/24
0.8264 -29.22%
on 11/12/24
+0.0568 (+10.76%)
since 09/13/24
52-Week
0.4115 +42.14%
on 09/26/24
4.2984 -86.39%
on 02/21/24
-1.6651 (-74.00%)
since 12/13/23

Most Recent Stories

More News
Athira Pharma Presents Promising Preclinical Data on ATH-1105 for Neuroprotection in ALS at International Symposium

Athira Pharma presented preclinical data on ATH-1105's neuroprotective effects in ALS at an international symposium in Montreal.Quiver AI SummaryAthira Pharma, Inc., a clinical-stage biopharmaceutical...

ATHA : 0.5849 (+0.50%)
Athira Pharma Presents Preclinical Data Highlighting Neuroprotective Effects of ATH-1105 in Models of ALS at Motor Neurone Disease Association’s 35th International Symposium on ALS/MND

ATHA : 0.5849 (+0.50%)
Athira Pharma Reports Third Quarter 2024 Financial Results and Pipeline and Business Updates

ATHA : 0.5849 (+0.50%)
Athira Pharma to Present Results from Phase 2/3 LIFT-AD Clinical Trial of Fosgonimeton at the Clinical Trials on Alzheimer’s Disease (CTAD) 2024 Meeting

ATHA : 0.5849 (+0.50%)
Johnson & Johnson: Taking The Bull By The Horns?

Johnson & Johnson is rushing toward a patent cliff but a new shelf offering registration suggests itis gearing up for acquisitions.

JNJ : 146.62 (+0.26%)
ABBV : 173.37 (+0.10%)
ATHA : 0.5849 (+0.50%)
ASND : 129.87 (-0.59%)
AZN : 66.58 (-0.54%)
Athira Pharma Presents Data from ACT-AD Phase 2 Proof-of-Concept Clinical Study of Fosgonimeton in Mild-to-Moderate Alzheimer’s Patients at the Alzheimer's Association International Conference 2022

Additional data showed numerical improvement in activities of daily living (ADCS-ADL23), a protocoled secondary endpoint and a functional measure of...

ATHA : 0.5849 (+0.50%)
Athira Pharma Presents Preclinical Data at the Alzheimer's Association International Conference 2022

Fosgo-AM, the active metabolite of Fosgonimeton (ATH-1017), demonstrates neuroprotective effects in primary neuron culturesNew orally available small...

ATHA : 0.5849 (+0.50%)
Athira Pharma to Present Clinical and Preclinical Data at Alzheimer’s Association International Conference 2022

BOTHELL, Wash., July 25, 2022 (GLOBE NEWSWIRE) -- Athira Pharma, Inc. (NASDAQ: ATHA), a late clinical-stage biopharmaceutical company focused on...

ATHA : 0.5849 (+0.50%)
Why Athira Pharma Stock Imploded Today

Its mid-stage clinical trial failed to help patients with Alzheimer's.

ATHA : 0.5849 (+0.50%)
Athira Pharma Announces Topline Results from ACT-AD Phase 2 Proof of Concept Study of Fosgonimeton in Mild-to-Moderate Alzheimer’s Disease

Primary endpoint of change in biomarker ERP P300 latency was not statistically significant for the full study population as combination of fosgonimeton and...

ATHA : 0.5849 (+0.50%)

Business Summary

Athira Pharma Inc. is a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and stop neurodegeneration. Athira Pharma Inc. is based in SEATTLE.

See More

Key Turning Points

3rd Resistance Point 0.6131
2nd Resistance Point 0.6016
1st Resistance Point 0.5932
Last Price 0.5849
1st Support Level 0.5733
2nd Support Level 0.5618
3rd Support Level 0.5534

See More

52-Week High 4.2984
Fibonacci 61.8% 2.8136
Fibonacci 50% 2.3549
Fibonacci 38.2% 1.8963
Last Price 0.5849
52-Week Low 0.4115

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar